Inhibiting aggressive breast cancer progression by targeting cell changes
Targeting lineage plasticity to inhibit basal-like breast cancer progression
This study is looking at a tough type of breast cancer called basal-like breast cancer, which mainly affects younger women and those of African descent, to find out how it develops and to discover new ways to stop it from getting worse.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11049844 on NIH RePORTER |
What this research studies
This research focuses on understanding and targeting the aggressive subtype of breast cancer known as basal-like breast cancer (BLBC), which primarily affects younger women and those of African ancestry. The study aims to investigate the cellular changes that lead to the progression of this cancer type, particularly how certain cells can revert to a more primitive state that promotes malignancy. By exploring the role of specific genetic factors, the research seeks to develop new strategies to prevent the transition from precancerous conditions to BLBC, potentially leading to more effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include younger women, particularly those of African descent or those with BRCA1 mutations, who are diagnosed with basal-like breast cancer.
Not a fit: Patients with other subtypes of breast cancer or those who do not have the specific genetic factors associated with basal-like breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for basal-like breast cancer, improving outcomes for affected patients.
How similar studies have performed: Previous studies have shown promise in targeting lineage plasticity in cancer, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Guo, Wenjun — Albert Einstein College of Medicine
- Study coordinator: Guo, Wenjun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.